DNA and Gene Cloning Services Market Size & Growth Forecast 2027–2036, By Segments (End Use, Service, Application), Regional Demand Trends (North America, Asia Pacific, Europe), Key Country Insights (U.S., Japan, South Korea, Germany, France, Italy), and Competitive Landscape
Market Size and Growth Outlook
DNA and Gene Cloning Services Market size stood at USD 3.3 billion in 2026 and is predicted to grow at a 15.11% CAGR from 2027 to 2036, reaching USD 13.48 billion by 2036. The industry revenue for 2027 is assessed at USD 3.72 billion.
Get more details on this report
Request Free Sample ReportDNA and Gene Cloning Services Market Intelligence Snapshot
Regional Market Dynamics
- North America held a 43.61% market share in 2026, supported by advanced research infrastructure, a strong biotechnology ecosystem, and widespread outsourcing for drug discovery and synthetic biology projects.
- Asia Pacific is projected to expand at a 17.14% CAGR as life sciences research, biotechnology manufacturing, and outsourced molecular biology services gain momentum across the region.
Segment Momentum
- Gene Synthesis accounted for 42.62% of the market in 2026 because it delivers accurate, ready-to-use genetic constructs while simplifying project workflows by eliminating labor-intensive template preparation and sequence assembly.
- Custom Cloning is expanding quickly as researchers and outsourced development teams increasingly require tailored constructs, vector compatibility, and specialized genetic modifications for project-specific research and development workflows.
Market Expansion Drivers
- Expanding gene therapy and personalized medicine demand accelerating cloning services adoption.
- Rising academic and biotech research outsourcing driving gene synthesis service utilization.
- Growth in CRISPR-based research outsourcing expanding synthetic biology service demand.
Leading Market Participants
- Key players in the DNA and gene cloning services market include Thermo Fisher Scientific Inc. (United States), Danaher Corporation (United States), Merck KGaA (Germany), GenScript Biotech Corporation (China), Twist Bioscience Corporation (United States), Charles River Laboratories International, Inc. (United States), Eurofins Scientific SE (Luxembourg), Bio-Techne Corporation (United States), Syngene International Limited (India), Curia Global, Inc. (United States).
Global Market Forecast Snapshot
Market Outlook
- 2026 Market Size: USD 3.3 billion
- 2027 Estimated Market Size: USD 3.72 billion.
- Projected Market Size: USD 13.48 billion by 2036
- Growth Forecast: 15.11% CAGR (2027-2036)
Regional and Segment Outlook
- Leading Regional Market: North America
- High-Growth Regional Hub: Asia Pacific
- Core Revenue Segment: Academic & Research Institutes (End Use) | Gene Synthesis (Service) | DNA Sequencing (Application)
- Emerging Opportunity Segment: CMOs & CROs (End Use) | Custom Cloning (Service) | Mutagenesis (Application)
Market Growth Drivers and Industry Trends
Expanding gene therapy and personalized medicine demand accelerating cloning services adoption
The growing development of gene-based treatments and individualized therapeutic approaches is strengthening the DNA and gene cloning services market by increasing the need for reliable genetic constructs and customized molecular biology workflows. Gene cloning is used in research and development activities involving therapeutic targets, expression systems, vector construction, and validation of genetic sequences, making it an important supporting capability for advanced biomedical programs. As researchers investigate treatments tailored to specific biological characteristics and disease mechanisms, demand is increasing for specialized cloning expertise that can support complex projects while reducing the technical burden on internal research teams.
Rising academic and biotech research outsourcing driving gene synthesis service utilization
Outsourcing is becoming increasingly attractive to academic laboratories and biotechnology organizations seeking access to specialized molecular biology capabilities without investing heavily in additional infrastructure and technical personnel. This shift is supporting the DNA and gene cloning services market as external providers can perform gene synthesis, sequence assembly, cloning, and related workflows according to project-specific requirements. Outsourced services can also help research teams manage fluctuating project volumes and accelerate experimental workflows by transferring technically intensive processes to specialized laboratories. The growing emphasis on research efficiency and resource optimization is encouraging greater use of external gene synthesis and cloning capabilities across diverse biological research programs.
Growth in CRISPR-based research outsourcing expanding synthetic biology service demand
The increasing use of CRISPR technologies in genetic engineering and functional genomics is opening additional applications for specialized cloning and synthetic biology services. In the DNA and gene cloning services market, CRISPR-based research often requires carefully designed DNA constructs, donor templates, guide-related components, and other genetic materials that support targeted experimental workflows. Outsourcing these requirements can provide researchers with access to specialized design and molecular biology capabilities while allowing internal teams to concentrate on downstream experiments and biological analysis. Broader adoption of genome editing across research settings is consequently increasing the need for customized genetic engineering support and associated synthetic biology services.
| Growth Driver | Impact on CAGR | Regulatory Influence | Geographic Relevance | Adoption Rate | Impact Timeline |
|---|---|---|---|---|---|
| Expanding gene therapy and personalized medicine demand accelerating cloning services adoption | 2.70% | High | North America, Europe | Medium | Mid Term |
| Rising academic and biotech research outsourcing driving gene synthesis service utilization | 2.20% | Moderate | North America, Asia Pacific | High | Mid Term |
| Growth in CRISPR-based research outsourcing expanding synthetic biology service demand | 1.90% | High | North America, Europe, Asia Pacific | Emerging | Long Term |
Unlock insights tailored to your business with our bespoke market research solutions.
Click to get your customized report now.
Regional Demand Dynamics
North America (Largest Region)
North America accounted for a 43.61% share of the DNA and gene cloning services market in 2026, reflecting its highly developed biotechnology ecosystem, advanced research infrastructure, and strong demand for molecular biology services. Extensive activity in genomics, drug discovery, therapeutic development, and academic research supports sustained outsourcing of specialized cloning work. Access to sophisticated laboratory capabilities and strong investment in life sciences also enables researchers and biotechnology organizations to accelerate experimental workflows and develop increasingly complex genetic constructs.
Asia Pacific (Fastest-Growing Region)
Asia Pacific is the fastest-growing region, supported by expanding biotechnology capabilities, increasing research activity, and growing investment in genomics and molecular biology infrastructure. Improvements in laboratory facilities and rising demand for outsourced research services are broadening the use of DNA and gene cloning technologies across pharmaceutical, biotechnology, agricultural, and academic applications. The region’s expanding life sciences ecosystem and growing focus on advanced genetic research are expected to further strengthen demand for specialized cloning services.
| Parameter | North America | Asia Pacific | Europe | Latin America | MEA |
|---|---|---|---|---|---|
| Innovation Hub i Scale Nascent Developing Advanced | |||||
| Cost-Sensitive Region i Scale Low Medium High | |||||
| Regulatory Environment i Scale Restrictive Neutral Supportive | |||||
| Demand Drivers i Scale Weak Moderate Strong | |||||
| Development Stage i Scale Emerging Developing Developed | |||||
| Adoption Rate i Scale Low Medium High | |||||
| New Entrants / Startups i Scale Sparse Moderate Dense | |||||
| Macro Indicators i Scale Weak Stable Strong |
Key Country Insights
Germany 🇩🇪
Applied Biotechnology SupportGermany prioritizes DNA and gene cloning services that strengthen industrial biotechnology and life sciences research. Research organizations and biotech firms increasingly require customized cloning solutions that support advanced molecular biology and precision medicine initiatives.
France 🇫🇷
Translational Research SupportFrance focuses on DNA and gene cloning services that facilitate translational research across public laboratories and biotechnology enterprises. Service providers are increasingly selected for their ability to deliver customized constructs supporting genomic and therapeutic development programs.
Italy 🇮🇹
Academic Research CollaborationItaly relies on DNA and gene cloning services to strengthen university research and biotechnology innovation projects. Research institutions increasingly partner with specialized laboratories that provide flexible cloning solutions and dependable technical expertise for molecular studies.
Japan 🇯🇵
High-Accuracy GenomicsJapan emphasizes DNA and gene cloning services with exceptional accuracy for pharmaceutical development and biomedical research. Laboratories increasingly value reliable service partners capable of supporting complex cloning workflows with consistent technical performance.
South Korea 🇰🇷
Biopharma Development PlatformSouth Korea expands use of DNA and gene cloning services to support growing biopharmaceutical research and synthetic biology activities. Companies increasingly collaborate with specialized providers offering rapid project execution and advanced molecular engineering capabilities.
United States 🇺🇸
Innovation Research HubThe U.S. maintains strong demand for DNA and gene cloning services from biotechnology companies, pharmaceutical developers, and academic research institutions. Organizations increasingly outsource cloning projects to accelerate therapeutic research while maintaining high quality and reproducibility standards.
Segment Leadership and Growth Trends
DNA and Gene Cloning Services Market Share (%), by End Use, 2026
Go beyond the chart, access full insights & data tables
Request Free Sample ReportEnd Use Segment Analysis: Academic & Research Institutes (Largest Segment) vs CMOs & CROs (Fastest-Growing Segment)
Academic & research institutes accounted for the largest share of the DNA and gene cloning services market in 2026, supported by sustained demand for molecular biology research, genetic studies, functional genomics, and experimental development. These institutions rely on cloning services to support a broad range of research activities, while increasing emphasis on advanced biotechnology and life sciences research continues to reinforce their use of specialized external capabilities.
CMOs & CROs represent the fastest-growing end-use segment, as pharmaceutical, biotechnology, and research organizations increasingly outsource specialized genetic engineering activities to external service providers. Outsourcing enables access to technical expertise, specialized infrastructure, and flexible project support, particularly as drug discovery, biologics development, and molecular research become more complex.
Service Segment Analysis: Gene Synthesis (Largest Segment) vs Custom Cloning (Fastest-Growing Segment)
The gene synthesis segment held the largest share of the DNA and gene cloning services market in 2026, driven by growing demand for precisely designed genetic sequences across research, therapeutic development, and biotechnology applications. Advances in synthetic biology and the increasing need for customized DNA constructs are supporting adoption, while researchers benefit from faster access to sequences tailored to specific experimental objectives.
Custom cloning is the fastest-growing service segment as researchers increasingly require specialized constructs designed around specific genes, vectors, expression systems, and experimental requirements. The expanding complexity of genetic research is increasing demand for flexible cloning workflows that can be adapted to individual projects, supporting broader use of customized service solutions.
| Segment | Sub-Segment | Largest Segment | Fastest Growing |
|---|---|---|---|
| End Use | Academic & Research Institutes, Pharmaceutical & Biotechnology Companies, CMOs & CROs | Academic & Research Institutes | CMOs & CROs |
| Service | Gene Synthesis, Custom Cloning, Sub-cloning, Others | Gene Synthesis | Custom Cloning |
| Application | DNA Sequencing, Mutagenesis, Genotyping, Others | DNA Sequencing | Mutagenesis |
Competitive Landscape and Market Positioning
Top players in the DNA and gene cloning services market:
1. Thermo Fisher Scientific Inc. (United States)
2. Danaher Corporation (United States)
3. Merck KGaA (Germany)
4. GenScript Biotech Corporation (China)
5. Twist Bioscience Corporation (United States)
6. Charles River Laboratories International Inc. (United States)
7. Eurofins Scientific SE (Luxembourg)
8. Bio-Techne Corporation (United States)
9. Syngene International Limited (India)
10. Curia Global Inc. (United States)
The DNA and gene cloning services market is evolving with increasing adoption of advanced molecular biology techniques. Continuous scientific development is improving accuracy and efficiency in genetic manipulation processes. Collaborative research initiatives are expanding service capabilities across biotechnology applications. The DNA and gene cloning services market is growing as demand rises for advanced genetic research and therapeutic development support.
| Company | Market Share | Company Revenue | Revenue CAGR (%) | Product Portfolio | Geographic Presence | Innovation / R&D Focus | Strategic Developments |
|---|---|---|---|---|---|---|---|
| Thermo Fisher Scientific Inc. (United States) | |||||||
| Danaher Corporation (United States) | |||||||
| Merck KGaA (Germany) | |||||||
| GenScript Biotech Corporation (China) | |||||||
| Twist Bioscience Corporation (United States) | |||||||
| Charles River Laboratories International Inc. (United States) | |||||||
| Eurofins Scientific SE (Luxembourg) | |||||||
| Bio-Techne Corporation (United States) | |||||||
| Syngene International Limited (India) | |||||||
| Curia Global Inc. (United States). |
Industry Development/News
| Company Name | Date | Key Development |
|---|---|---|
| Twist Bioscience | May-25 | Twist Bioscience expanded its collaboration with Ginkgo Bioworks through enhanced licensing of long DNA technologies, strengthening its DNA synthesis capabilities. The development supports higher demand for gene cloning services by improving synthesis scalability and expanding the company’s high-throughput DNA engineering and construct generation capacity for research and industrial applications. |
| GenScript Biotech Corporation | Jun-24 | GenScript Biotech launched its FLASH gene synthesis service, significantly reducing sequence-to-plasmid turnaround time. The service supports accelerated R&D workflows in antibody development, vaccine research, and cell and gene therapy, strengthening GenScript’s competitive positioning in high-speed gene cloning and synthetic biology services. |
| Twist Bioscience | May-24 | Twist Bioscience launched Multiplexed Gene Fragments enabling pooled synthesis of DNA sequences up to 500 base pairs. The capability enhances high-throughput screening workflows and strengthens gene cloning service offerings by improving synthesis efficiency and supporting scalable DNA construct generation for research and biotechnology applications. |
| Twist Bioscience | Nov-23 | Twist Bioscience introduced Twist Express Genes, a scalable gene synthesis solution designed to deliver clonal genes and gene fragments with faster turnaround times. The offering enhances the company’s gene cloning service portfolio by improving throughput and accelerating DNA construct delivery for research and industrial biotech applications. |
Customize Your Report
Explore examples of how this report can be tailored to different research needs, including custom segments, additional topics or chapters, and related reports. Click a section of the wheel or its numbered marker to explore the available options.
DNA and Gene Cloning Services Market — Custom Segments
| Segment | Sub-Segment |
|---|---|
| Therapeutic Area | Oncology, Infectious Diseases, Genetic Disorders, Immunology, Neurology, Cardiovascular & Metabolic Diseases, Other Therapeutic Areas |
| Project Scale | Small-Scale Research Projects, Medium-Scale Research Projects, Large-Scale Development Projects, High-Throughput Projects |
| Development Stage | Discovery & Basic Research, Preclinical Development, Clinical Development, Commercial Development |
DNA and Gene Cloning Services Market — Custom TOC
| Custom Chapter | Custom Details |
|---|---|
| Synthetic Biology Application and Service Opportunities |
|
| Gene Cloning Outsourcing and Workflow Transformation |
|
| Therapeutic Development and Research Demand |
|
Need a different cut of the data?
Request Custom ResearchWhat is the market valuation of DNA and gene cloning services?
What is the projected value of the DNA and gene cloning services industry by 2036?
How is growth in gene therapy and personalized medicine shaping demand for DNA and gene cloning services?
Why is research outsourcing accelerating adoption of DNA and gene cloning services?
Why does gene synthesis lead the DNA and gene cloning services market?
Why is custom cloning the fastest-growing service segment?
Why does North America lead the DNA and gene cloning services market?
What is fueling growth in the DNA and gene cloning services market across Asia Pacific?
Which companies dominate the DNA and gene cloning services landscape?
Our Clients
"The team took the time to understand our specific business needs and delivered a report that was well aligned with our objectives. Their expertise and understanding of the industry were clearly reflected in the quality and relevance of the insights provided."
Siemens Healthcare
"Our experience in acquiring the research report has been excellent. The depth of analysis, and actionable insights provided have been extremely valuable in supporting our ongoing R&D efforts."
GC Biopharma
"The report offered a comprehensive view of the market trends. The in-depth segmentation and analysis of emerging opportunities gave us a better understanding of the market."
Medtronic
Our Research Team & Methodology
Every Fundamental Business Insights report is built by a dedicated vertical research team, validated through a structured primary-and-secondary methodology, and reviewed for accuracy before it reaches you.
Research Team Overview
Prepared by the Healthcare & Medical Devices Research Team
Delivery
Published
Demand
Available
Support
Trust & Compliance
Research Domains
10 coverage areasResearch Intelligence
| Source | Reference |
|---|---|
| World Health Organization (WHO) | www.who.int |
| U.S. Food & Drug Administration (FDA) | www.fda.gov |
| European Medicines Agency (EMA) | www.ema.europa.eu |
| Centers for Disease Control and Prevention (CDC) | www.cdc.gov |
| National Institutes of Health (NIH) | www.nih.gov |
| National Center for Biotechnology Information (NCBI) | www.ncbi.nlm.nih.gov |
| PubMed | pubmed.ncbi.nlm.nih.gov |
| ClinicalTrials.gov | clinicaltrials.gov |
| International Organization for Standardization (ISO) | www.iso.org |
| ASTM International | www.astm.org |
| Advanced Medical Technology Association (AdvaMed) | www.advamed.org |
| Medical Device Innovation Consortium (MDIC) | mdic.org |
| Biotechnology Innovation Organization (BIO) | www.bio.org |
| International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) | www.ifpma.org |
| U.S. Pharmacopeia (USP) | www.usp.org |
| European Directorate for the Quality of Medicines & HealthCare (EDQM) | www.edqm.eu |
| World Organisation for Animal Health (WOAH) | www.woah.org |
| American Hospital Association (AHA) | www.aha.org |
| OECD Health | www.oecd.org/health |
| World Bank Data | data.worldbank.org |
Research Workflow & Quality Assurance
Data Collection
Verified information gathered through primary and secondary research.
Data Triangulation
Cross-validation using multiple independent data sources.
Forecast Modelling
Market estimates developed using historical trends and analytical models.
Analyst Validation
Findings reviewed by domain experts for accuracy and consistency.
Editorial & Quality Review
Final editorial, quality, and compliance checks before publication.
Final Publication
Released after successful completion of the internal review process.
Report Coverage
📊 Market Assessment
- Market Size & Forecast
- Market Segmentation
- Regional Analysis
- Growth Drivers & Challenges
- Market Dynamics
🏢 Competitive Intelligence
- Competitive Landscape
- Company Profiles
- Competitive Benchmarking
- Mergers & Acquisitions
- Market Share Analysis or Key Company Strategies
🔍 Strategic Analysis
- Value Chain Analysis
- Porter's Five Forces
- PESTLE Analysis
- Pricing Trends
- Supply-Demand Analysis
🚀 Future Outlook
- Technology Landscape
- Regulatory Landscape
- Investment & Funding Landscape
- Emerging Opportunities
- Future Market Outlook
Have a question about this report or need a custom scope?
Request Customization